R&D Director · NOVOS

The State of Longevity Medicine

Longevity researcher and R&D Director at NOVOS, focused on the molecular biology of aging. Diogo bridges academic geroscience and consumer longevity, translating decades of aging research into evidence-based interventions that can be used today.

Researcher on Aging & Asst. Professor of Immunology · i3s & NOVA Medical School

The State of Longevity Medicine

Researcher at i3s and Assistant Professor of Immunology at NOVA Medical School, Jose Pedro studies how inflammation accelerates biological aging. His work spans immune system aging, regenerative drug development, and multi-omics tools to predict inflammatory disease trajectories.

Medical Director · TejoMed

The State of Longevity Medicine

Family physician and Medical Director at TejoMed, with 11 years of clinical experience and a postgraduate in Health Administration. Luisa combines evidence-based medicine with a strong focus on patient empowerment, mental health, and women's health — bringing a frontline clinical perspective to longevity medicine.

PhD · Life Science Strategist & Brain Health

The State of Longevity Medicine

Life science strategist and speaker at the intersection of brain health, longevity, and entrepreneurship, holding a doctorate in Cell Biology from the University of São Paulo. With a decade of consulting across biotech, medtech, and pharma and a current role at an early-stage neurotechnology company focused on neural circuit repair, Matthew bridges scientific rigor with strategic vision — and believes healthy aging starts with a healthy mind.

Founder · The Miami Institute

The State of Longevity Medicine

Founder of The Miami Institute for age management medicine and former CSO of the Blue Zones Center at Miami Worldcenter. Twenty years at the intersection of longevity science, Special Economic Zone policy, and real estate — including the world's first Blue Zones-branded skyscraper.

Head of Neurodegenerative Disorders Pillar · PPD / Thermo Fisher

Design Your Longevity Protocol

Head of the Neurodegenerative Disorders Pillar at PPD/Thermo Fisher, overseeing clinical trials in dementia research. Founder of Be a Longevity Creator, Sabine designs practical longevity protocols for remote workers and corporates — translating clinical evidence into daily habits that actually stick.

Consumer Health Investor · naturalX

The LongBio Bet: Investing at the Frontier

Founder of naturalX Health Ventures, a €100M consumer healthcare fund investing at Series A and B. A serial entrepreneur turned investor, Marvin has built CPG, digital health, and e-commerce brands across Europe and the US, and now backs the founders shaping the next generation of longevity products.

Founder · 2060 Foundation

The LongBio Bet: Investing at the Frontier

Gabriel has spent 20 years in the tech space, creating and selling startups. When he was 40, he discovered that time — not money — was the ultimate limiting factor. This led him to create the 2060 Foundation, a whole ecosystem of initiatives to defeat aging before the year 2060, including the 2060 Investment Club, the 3060 Fund of Longevity Funds, the 2060 Longevity Forum, and Ikare.

Venture Partner · AdBio Partners

The LongBio Bet: Investing at the Frontier

Former CEO of Rejuveron, Aksana Labokha built and scaled a portfolio of longevity biotech companies, leading a $75M financing and multiple strategic transactions. A biotech investor and company builder, she has helped create six ventures turning ageing biology into venture-scale therapeutics. Now a Venture Partner at AdBio Partners, she leads the Longevity Vertical, backing companies targeting the root causes of ageing.

Founder · Noēsis — The Longevity Collective

The LongBio Bet: Investing at the Frontier

Thomas Weidlich is the founder of Noēsis — The Longevity Collective, a curated mastermind bringing together founders, scientists, doctors, and investors shaping the future of longevity. His core conviction: your five closest relationships are more predictive of your healthspan than your supplement stack. With over a decade in facilitation and community design, he has spoken at Life Summit, the Conscious Health Summit, and the SIP Global Health Conference.

Chair of Molecular Biogerontology · University of Birmingham

Overview of Longevity Research

Internationally recognized researcher working at the intersection of genomics, data science, and ageing biology. Following training in genetics at Harvard Medical School, he established his research group in England, where his lab combines experimental and computational approaches to understand ageing and develop strategies to prevent age-related diseases and improve human health.

Epigenetic Testing

Genetics and molecular biology expert turned wellness and longevity consultant. Works with brands and medtech startups to drive growth through personalised healthcare and prevention-focused innovation. Past collaborators include Danone, L'Occitane, Edwards Lifesciences, and Medtronic. Science background at Masaryk University and Universidad de Santiago de Compostela, combined with hands-on marketing and commercial experience.

Longevity Trends in Women's Health

Founded and led a six-week longevity-focused pop-up city in Berlin, spanning science, entrepreneurship, and decentralised research. Produced 5 interdisciplinary conferences and hosted 30 residents plus 150–200 weekend attendees. Secured Gitcoin funding with support from Vitalik Buterin. Speakers included George Church, Aubrey de Grey, Andrea Maier, Oliver Zolman, and Morten Scheibye-Knudsen.